Head and neck cancers in young adults less likely due to lifestyle factors
the ONA take:
According to a new study published in the International Journal of Epidemiology, researchers have found that head and neck cancer in young adults is more likely to occur as a result of inherited factors rather than lifestyle factors.
For the study, researchers analyzed data from 25 studies from the International Head and Neck Cancer Epidemiology (INHANCE) consortium to determine the effect of inherited and lifestyle risk factors in heck and neck cancer in adults under and older 45 years of age.
All participants were asked about their lifestyle habits, such as cigarette smoking, alcohol drinking, and diet, and family history of cancer. They found 2,010 cases of head and neck cancer and 4,042 control cases in young adults, and 17,700 cases of head and neck cancer and 22,704 control cases in older adults.
Analyses showed that if smoking was eliminated, 46% of cases in young men, 64% in older men, 20% in young women, and 49% in older women would have been avoided. If drinking alcohol were eliminated, 22% of cases in young men, 50% in older men, 5% in young women, and 20% in older women would have been avoided.
They also found that only older people had an increased risk for head and neck due to family history of any cancer type, but a family history of early-onset cancer increased the risk of head and neck cancer in younger adults.
Head and neck cancer in young adults is more likely to occur as a result of inherited factors rather than lifestyle factors.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|